Sustained release suppositories and a process for preparation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5436009
SERIAL NO

07990888

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A sustained release suppository comprising in a usual suppository base a) a water-soluble therapeutically active substance, the average particle size of which is smaller than 20 .mu.m, b) a physiologically acceptable organic substance which is swellable in contact with water, and c) hydrophobic silicium dioxide. The suppository base is usually a fat having a melting range of from 29.degree. to 38.degree. C. As ingredient b) cellulose derivatives such as hydroxypropylmethylcellulose may be used, in a quantity of from 5 to 40% by weight, preferably 9 to 15% by weight. Ingredient c) is preferably used in a quantity of from 3 to 6% by weight. Also a process for manufacturing the suppositories is described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DAGRA PHARMA B VNL-1112 AX DIEMEN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Frijlink, Hendrik W Huizen, NL 1 13
Jauw, Tjoe H Amsterdam, NL 4 22
Meijlink, Peter Oosthuizen, NL 2 13
Moolenaar, Frits Stitswerd, NL 2 17

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation